#INTK Nice when the word our main contact at a new large
#INTK Nice when the word our main contact at a new large multinational customer uses to describe their first trial of EPX-H20 on a big critical piece of industrial heat process equipment is "astounding". They are sending a corporate wide memo about amazing & immediate results.
4 replies 7 retweets 18 likes
INIWorldWide
@INIWorldWide
Jul 26
#INTK INTK has the best shareholders... bold brash critics who don't mind calling us out, ardent supporters who cheer us on, the quiet committed ones large and small holding their position or doubling down in the dips. Don't think we don't notice and appreciate all.
10 replies 12 retweets 21 likes
INIWorldWide
@INIWorldWide
Jul 26
#INTK Major retailer tried our products on skylights. It worked... of course. Now working on rollout to all properties. Will take time because they don't move fast. FYI... our coating blocks 80% of damaging UV rays but allows 92% of visible light through while keeping heat out.
0 replies 8 retweets 14 likes
INIWorldWide
@INIWorldWide
Jul 26
#INTK Shareholders: We received email confirm from transfer agent late yesterday that they had provided OTCMarkets information requested to approve our filings. Process of getting current information published and status changed almost completed.
3 replies 10 retweets 21 likes
INIWorldWide
@INIWorldWide
Jul 20
#INTK One day after successful application of EPX on big oven of global metals manufacturer we have call with manufacturer of polymers for aerospace, marine, & subsea industries. They have big ovens & want EPX. From metals to polymers, we make manufacturers more energy efficient.
4 replies 8 retweets 22 likes
INIWorldWide
@INIWorldWide
Jul 20
#INTK Forms & fees sent & paid to OTCIQ now just waiting for approval & publishing of Disclosure Documents & Financials & be changed to "Current Information". Receipt of pmnt & forms confirmed. Will be nice to be back to our normal routine of current filings we kept for a decade.
5 replies 12 retweets 32 likes
INIWorldWide
@INIWorldWide
Jul 19
#INTK Financials and 15c-211 finish review tomorrow. Then filed electronically on OTCMarkets through OTCIQ. Takes them approx 3 business days to publish & change status to "Current Information". Numbers are good. Future bright. Thank you shareholders for your continued support.
6 replies 14 retweets 27 likes
INIWorldWide
@INIWorldWide
Jul 18
#INTK Global metal manufacturer VERY pleased!!! After only 2 coats yesterday thermal imaging already shows significant difference on industrial oven. “Big wigs" in town & impressed. Choosing more projects for us. Their maintenance crew said “easy to apply!” Finishing today.
2 replies 4 retweets 19 likes
Industrial Nanotech (INTK) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...
Continue Reading
Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...
Continue Reading
Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...
Continue Reading
A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...
Continue Reading
Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...
Continue Reading
Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...
Continue Reading
High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...
Continue Reading
New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...
Continue Reading
Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...
Continue Reading
Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...
Continue Reading
Top 5 Most Recently Viewed Articles
A Surge in After-Hours Trading for Flora Growth Corp Flora Growth Corp. (NASDAQ: FLGC) recently demonstrated significant volatility by surging 5.98% to $10.55 during after-hours trading. This movement came not long after closing at $9.96, which marked an increase of 3.59% earlier that day. Insights from Recent SEC Filing Regulation A Filing In a notable move, Flora Growth...
Continue Reading
Qubs Launches Qubitunes for Creative Play Qubs has unveiled an exciting new product, Qubitunes, which has already won the 'Top Toy' award in the startup category at a prestigious Toy Fair. This innovative toy is set to transform playtime for children by offering a unique platform where they can express their creativity and dive into their own audio storytelling...
Continue Reading
Asyad Group's Successful Transport of Cryogenic Tank Asyad Group has recently completed a remarkable international transport operation, successfully moving a 115 metric ton pressurized cryogenic tank from Northern India to a major destination in Saudi Arabia. This endeavor highlights the Group's expertise in cross-border logistics. A Journey of Precision The transport...
Continue Reading
Famous Toastery's Compassionate Campaign for Local Communities The Famous Toastery, known for its delightful breakfast and brunch offerings, is stepping up this holiday season with a noble initiative aimed at fighting hunger. This renowned franchise is collaborating with Feeding the Carolinas, encouraging guests to make donations that will significantly impact individuals...
Continue Reading
Jiayin Group Inc. Announces Q3 2025 Financial Results Release Jiayin Group Inc. (NASDAQ: JFIN), a prominent fintech platform in China, has shared significant news that it will unveil its unaudited financial outcomes for the third quarter of 2025. This crucial announcement is set to occur before the U.S. markets open on November 25, 2025. The anticipation surrounding these...
Continue Reading